BridgeMD
New treatment option for Psychosis of Childhood Borderline
Official title Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
ClinicalTrials.gov ID: NCT04945278
What this study is testing
- What it's testing
- The main objective of this study is to establish whether there are differences in self-recognition and self/other distinction in subjects with psychological vulnerability compared to healthy volunteer controls.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 25. Healthy volunteers may be eligible.
You may be able to join if
- for patients:
- Aged from 15 to 25 years
- Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A
- Signature of the consent (participants and parents for minors)
- Subject affiliated to the social security scheme or benefiting from such a scheme for healthy volunteers:
You likely can't join if
- for both patients and healthy volunteers:
- History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli)
- Refusal of participation of the minor even if the legal representatives want the subject to participate in the study
- Claustrophobia
- Wearing glasses
- Abnormal right and left visual acuity without contact lenses
See the full eligibility criteria
- for patients:
- Aged from 15 to 25 years
- Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A
- Signature of the consent (participants and parents for minors)
- Subject affiliated to the social security scheme or benefiting from such a scheme for healthy volunteers:
- Aged from 15 to 25 years
- Subject not familiar to the patient to whom it is matched
- Signature of the consent (participants and parents for minors)
- Subject affiliated to the social security scheme or benefiting from such a scheme
- for both patients and healthy volunteers:
- History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli)
- Refusal of participation of the minor even if the legal representatives want the subject to participate in the study
- Claustrophobia
- Wearing glasses
- Abnormal right and left visual acuity without contact lenses
- Distinctive signs on the face which cannot be temporarily removed
- Subject under legal protection (curators / guardianship) or deprived of liberty
The study team makes the final eligibility decision.
Where it's taking place
- Bohars, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 25 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bohars, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.